Practice Guideline
doi: 10.1002/hep.29913.
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Affiliations
- PMID: 29624699
- DOI: 10.1002/hep.29913
Item in Clipboard
Practice Guideline
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Hepatology.
2018 Aug.
No abstract available
Comment in
-
A New Concept: Pre-HCC Disease.Hepatology. 2018 Oct;68(4):1662. doi: 10.1002/hep.30154. Hepatology. 2018. PMID: 30070377 No abstract available.
Similar articles
-
From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.World J Gastroenterol. 2017 Aug 7;23(29):5282-5294. doi: 10.3748/wjg.v23.i29.5282. World J Gastroenterol. 2017. PMID: 28839428 Free PMC article. Review.
-
Management of hepatocellular carcinoma in the age of liver transplantation.Int J Surg. 2009 Aug;7(4):324-9. doi: 10.1016/j.ijsu.2008.12.041. Epub 2009 Jan 6. Int J Surg. 2009. PMID: 19643691 Review.
-
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol. 2018 Oct 1;29(Suppl 4):iv238-iv255. doi: 10.1093/annonc/mdy308. Ann Oncol. 2018. PMID: 30285213 No abstract available.
-
Hepatocellular carcinoma in children.Clin Liver Dis. 2015 May;19(2):433-47. doi: 10.1016/j.cld.2015.01.010. Epub 2015 Feb 28. Clin Liver Dis. 2015. PMID: 25921672 Review.
-
Hepatocellular carcinoma: current approaches to diagnosis and management.Intern Med J. 2002 Aug;32(8):394-400. doi: 10.1046/j.1445-5994.2002.00227.x. Intern Med J. 2002. PMID: 12162396 Review.
Cited by
-
Dynamic changes of radiological and radiomics patterns based on MRI in viable hepatocellular carcinoma after transarterial chemoembolization.Abdom Radiol (NY). 2024 Nov 15. doi: 10.1007/s00261-024-04676-z. Online ahead of print. Abdom Radiol (NY). 2024. PMID: 39542948
-
PKR associates with 4.1R to promote anchorage-independent growth of hepatocellular carcinoma and lead to poor prognosis.Sci Rep. 2024 Nov 13;14(1):27768. doi: 10.1038/s41598-024-75142-5. Sci Rep. 2024. PMID: 39532917 Free PMC article.
-
Progression of chronic liver disease to hepatocellular carcinoma: implications for surveillance and management.BJC Rep. 2024 May 3;2(1):39. doi: 10.1038/s44276-024-00050-0. BJC Rep. 2024. PMID: 39516538 Free PMC article.
-
Hepatocellular carcinoma risk prediction and early detection in patients with metabolic dysfunction associated steatotic liver disease.Transl Gastroenterol Hepatol. 2024 Oct 12;9:67. doi: 10.21037/tgh-24-41. eCollection 2024. Transl Gastroenterol Hepatol. 2024. PMID: 39503040 Free PMC article. Review.
-
Safety and efficacy of DEB-TACE in combination with lenvatinib and camrelizumab for the treatment of unresectable hepatocellular carcinoma (uHCC): a two-centre retrospective study.Front Immunol. 2024 Oct 22;15:1422784. doi: 10.3389/fimmu.2024.1422784. eCollection 2024. Front Immunol. 2024. PMID: 39502690 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
